Retour
Prix Psyence Biomedical Ltd (PBM)
Graphique du cours de l'action PBM
PBM Dividendes
Psyence Biomedical Ltd
$0.67
-0.01%
$0
À la fermeture : Jan 16, 16:00:00 GMT-5
$0.68
1.62%
$0.01
Post-Marché: Jan 16, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$0.6701
Prix d'ouverture
$0.6882
Plage de la journée
$0.6167 - $0.69
Plage de 52 semaines
$0.662 - $17.93
Volume
506.8K
Volume moyen
1.3M
BPA (TTM)
41.27
Rendement en dividend
--
Capitalisation boursière
$1.2M
Qu’est-ce que PBM ?
Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. The company is headquartered in Toronto, Ontario and currently employs 12 full-time employees. The company went IPO on 2021-12-10. The firm is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved
